Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004321203 | SCV003984323 | uncertain significance | not specified | 2023-05-17 | criteria provided, single submitter | clinical testing | The c.3342C>A (p.D1114E) alteration is located in exon 16 (coding exon 16) of the NPC1L1 gene. This alteration results from a C to A substitution at nucleotide position 3342, causing the aspartic acid (D) at amino acid position 1114 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |